In a Time of Universal Deceit, Telling the Truth is Revolutionary.
Tuesday, December 6, 2022

F.D.A. Reviewing H.I.V. Drugs for Heart Risk

The Food and Drug Administration said that recent data show patients taking H.I.V. drugs from GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart attack.
Facebook
Twitter
LinkedIn

The Food and Drug Administration said that recent data show patients taking H.I.V. drugs from GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart attack.

%d bloggers like this: